For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Akouos, Inc.

USPTO Granted Patents = 15

Trademarks = 11

Forward Citations = 39

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Emmanuel John Simons (15 out of 15 patents)

Robert Ng (10 out of 11 patents)

Ellen Reisinger (6 out of 6 patents)

4. Sebastian Kügler (6 out of 7 patents)

5. Hanan Al-Moyed (6 out of 6 patents)

6. Michael J McKenna (4 out of 18 patents)

7. Hao Chiang (1 out of 1 patent)

8. Danielle Lenz (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 12703874 - METHODS OF TREATING HEARING LOSS USING A SECRETED TARGET PROTEIN (2026-08-11),

2. 12673116 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2026-07-07),

3. 12365726 - Anti-VEGF antibody constructs (2025-07-22),

4. 12305191 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2025-05-20),

5. 12275960 - AAV-mediated delivery of therapeutic antibodies to the inner ear (2025-04-14),

6. 12264317 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2025-04-01),

7. 12226493 - Methods of treating non-syndromic sensorineural hearing loss (2025-02-18),

8. 12077783 - AAV-mediated delivery of antibodies to the inner ear (2024-09-03),

9. 12077773 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-09-03),

10. 12071627 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-08-27),

11. 11993777 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-05-28),

12. 11807867 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2023-11-07),

13. 11781145 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2023-10-10),

14. 11697801 - AAV-mediated delivery of therapeutic antibodies to the inner ear (2023-07-11),

15. 11525139 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2022-12-13),

Company Overview

Akouos, Inc. is a biotechnology company based in Boston, MA, focused on developing innovative gene therapies for hearing loss. The company specializes in harnessing advanced genetic engineering techniques to restore and preserve auditory function. By targeting the underlying causes of hearing impairment, Akouos aims to transform the treatment landscape for individuals affected by various forms of hearing loss. Their research encompasses a range of therapeutic approaches, positioning them at the forefront of auditory health advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#146 in Boston, MA

#1,276 in Massachusetts

#21,052 in US

#39,921 in the World

Boston, MA, United States of America

Akouos, Inc.

Forward Citations = 39

8 inventors:

Emmanuel John Simons (15 out of 15 patents)

Robert Ng (10 out of 11 patents)

Ellen Reisinger (6 out of 6 patents)

4. Sebastian Kügler (6 out of 7 patents)

5. Hanan Al-Moyed (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akouos, Inc.. Retrieved from https://idiyas.com/company/akouos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…